Cibus (CBUS) Projected to Release Earnings on Thursday

Cibus (NASDAQ:CBUS) is expected to post its Q3 2026 results after the market closes on Thursday, November 12th. Analysts expect Cibus to announce earnings of ($0.2033) per share and revenue of $1.30 million for the quarter. Interested persons can find conference call details on the company’s upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Thursday, November 12, 2026 at 4:30 PM ET.

Cibus (NASDAQ:CBUS) last posted its earnings results on Thursday, August 13th. The company reported ($0.29) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.19) by ($0.10). Cibus had a negative net margin of 2,258.89% and a negative return on equity of 287.03%. The company had revenue of $0.99 million for the quarter, compared to analysts’ expectations of $1.70 million. On average, analysts expect Cibus to post ($1.13) EPS for the current fiscal year and ($1.07) EPS for the next fiscal year.

Cibus Trading Up 8.8%

Shares of CBUS opened at $1.24 on Thursday. The business’s 50-day moving average price is $1.50 and its 200-day moving average price is $1.84. Cibus has a twelve month low of $1.09 and a twelve month high of $4.19.

Wall Street Analyst Weigh In

A number of research firms have recently commented on CBUS. Wall Street Zen lowered shares of Cibus from a “hold” rating to a “sell” rating in a research report on Saturday, October 17th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Cibus in a report on Friday, September 25th. One equities research analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $9.00.

About Cibus

Cibus, Inc (NASDAQ: CBUS) is an agricultural biotechnology company focused on developing gene-edited crop traits. Its technology is designed to improve the performance, resilience and sustainability of important crops by making targeted changes to plant genetics without introducing foreign DNA.

The company’s proprietary Rapid Trait Development System (RTDS) supports the development of traits for crops including canola, rice, soybeans and wheat. Cibus has pursued applications such as herbicide tolerance, pod-shatter reduction and resistance to diseases and other environmental stresses, with the goal of helping growers improve yields, reduce crop losses and use agricultural inputs more efficiently.

Cibus serves the global agriculture industry through relationships with seed companies, growers and other participants in the crop-development and commercialization ecosystem.